- Home
- CNTB vs PRE Comparison
CNTB vs PRE Comparison
Compare CNTB & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- PRE
- Stock Information
- Founded
- CNTB 2012
- PRE 2014
- Country
- CNTB United States
- PRE Hong Kong
- Employees
- CNTB N/A
- PRE N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- CNTB Health Care
- PRE Industrials
- Exchange
- CNTB Nasdaq
- PRE Nasdaq
- Market Cap
- CNTB 65.5M
- PRE 72.6M
- IPO Year
- CNTB 2021
- PRE N/A
- Fundamental
- Price
- CNTB $1.06
- PRE $5.53
- Analyst Decision
- CNTB Strong Buy
- PRE Buy
- Analyst Count
- CNTB 1
- PRE 1
- Target Price
- CNTB $8.00
- PRE $9.00
- AVG Volume (30 Days)
- CNTB 31.2K
- PRE 13.0K
- Earning Date
- CNTB 09-05-2024
- PRE 11-27-2024
- Dividend Yield
- CNTB N/A
- PRE N/A
- EPS Growth
- CNTB N/A
- PRE N/A
- EPS
- CNTB N/A
- PRE N/A
- Revenue
- CNTB $24,116,000.00
- PRE $25,561,362.00
- Revenue This Year
- CNTB N/A
- PRE $64.44
- Revenue Next Year
- CNTB $63.90
- PRE $154.24
- P/E Ratio
- CNTB N/A
- PRE N/A
- Revenue Growth
- CNTB N/A
- PRE N/A
- 52 Week Low
- CNTB $0.77
- PRE $2.85
- 52 Week High
- CNTB $2.66
- PRE $7.84
- Technical
- Relative Strength Index (RSI)
- CNTB 46.58
- PRE 66.84
- Support Level
- CNTB $1.04
- PRE $5.06
- Resistance Level
- CNTB $1.23
- PRE $5.35
- Average True Range (ATR)
- CNTB 0.10
- PRE 0.20
- MACD
- CNTB 0.01
- PRE 0.09
- Stochastic Oscillator
- CNTB 42.37
- PRE 94.44
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.